Molecular Therapy: Methods & Clinical Development (Jan 2016)
Biodistribution studies: understanding international expectations
- Ying Huang,
- Mike Havert,
- Denise Gavin,
- Mercedes Serabian,
- Lee Lee Ong,
- Maritza C McIntyre,
- Nicolas Ferry,
- Akihiro Kume,
- Dino Petrin,
- Ying-Hsien Fu,
- Andreas Marti,
- Fabricio Oliveira,
- Sumol Pavittranon,
- Won Shin
Affiliations
- Ying Huang
- US Food and Drug Administration Silver Spring, Maryland, USA
- Mike Havert
- US Food and Drug Administration Silver Spring, Maryland, USA
- Denise Gavin
- US Food and Drug Administration Silver Spring, Maryland, USA
- Mercedes Serabian
- US Food and Drug Administration Silver Spring, Maryland, USA
- Lee Lee Ong
- Singapore- Health Sciences Authority, Singapore
- Maritza C McIntyre
- Bamboo Therapeutics, Inc Chapel Hill, North Carolina, USA
- Nicolas Ferry
- European Medicines Agency, London, UK
- Akihiro Kume
- Pharmaceutical and Medical Device Agency – Japan, Tokyo, Japan
- Dino Petrin
- Health Canada, Ottawa, Ontario, Canada
- Ying-Hsien Fu
- Taiwan Food and Drug Administration (Chinese Taipei), Taipei City, Taiwan
- Andreas Marti
- Swissmedic Berne, Switzerland
- Fabricio Oliveira
- National Health Surveillance Agency Brazil, Setor de Industria, Brazil
- Sumol Pavittranon
- Thailand Center of Excellence for Life Sciences, Phayathai Bangkok, Thailand
- Won Shin
- South Korea Ministry of Food and Drug Safety, Chungcheongbuk-do, Korea
- DOI
- https://doi.org/10.1038/mtm.2016.22
- Journal volume & issue
-
Vol. 3,
no. C
Abstract
No abstracts available.
